Chemicals start-up NuSynth raises Rs 36.5 crore seed round to cut import reliance
Representative image: jarmoluk / Pixabay
Bengaluru's NuSynth Technologies raised Rs 36.5 crore in a seed round co-led by Avaana Capital and Shastra VC, reported October 13, 2026.
What Happened
NuSynth Technologies, a Bengaluru start-up that uses software and laboratory work to design cheaper ways of making speciality chemicals, has raised Rs 36.5 crore in a seed round co-led by Avaana Capital and Shastra VC, according to reports published on Tuesday, October 13, 2026. Seven to eight angel investors also took part. The company, set up in 2026, says it will spend the money on research and technology, an initial set of proprietary manufacturing processes, scale-up capacity and hiring. It already runs a research laboratory and pilot plant in Mysuru and is building a second research facility in Bengaluru.
Key Facts
- Amount: Rs 36.5 crore seed round, co-led by Avaana Capital and Shastra VC, with seven to eight angel investors.
- NuSynth's platform evaluates raw materials, reaction routes and process costs to redesign how a chemical is made.
- Its stated goals are lower manufacturing costs, less use of resources and less dependence on imported chemical intermediates.
- It is starting with chemicals for the pharmaceutical and electronics industries and plans to move later into nutraceuticals, flavours and fragrances.
- The company says it is working on four to five molecules at present.
- Its founders are named as Poorvank Purohit, Ramesha A R, Abhishek Deo and Dipak Bajaj.
Why It Matters
Speciality chemicals are the ingredients behind medicines, electronics, crop protection and consumer goods. India makes many such chemicals but still buys many of the intermediates that go into them from abroad, which is why import dependence comes up often in discussions about manufacturing self-reliance.
NuSynth's pitch is that better process chemistry, not only bigger plants, is the way to compete. If a molecule can be made through a shorter route, with cheaper inputs and less waste, an Indian manufacturer can match imported prices. This is the logic investors are backing: a seed round of Rs 36.5 crore is large for a company this young, and it reflects interest from climate- and deep-tech funds in businesses that cut both cost and resource use.
For readers looking at sector opportunities, the deal points to a wider trend: early-stage investors in India are moving into science-heavy, capital-intensive fields such as chemicals, materials and manufacturing technology. These businesses take longer to reach revenue than software start-ups, but they can sell into large existing industries. The risk is equally clear. A process that works in a pilot plant still has to be scaled to commercial volumes and sold to cautious buyers in pharma and electronics, where quality approvals take time.
| | Detail | Information | |
|---|---|
| | Round | Seed, Rs 36.5 crore | |
| | Co-leads | Avaana Capital, Shastra VC | |
| | Facilities | R&D lab and pilot plant in Mysuru; Bengaluru lab under development | |
| | First markets | Pharmaceutical and electronics chemicals | |
Impact
Short-term: NuSynth plans to hire scientists and engineers, develop its first proprietary processes and expand its pilot capacity.
Long-term: If its processes reach commercial scale, Indian drug and electronics makers could source some chemical intermediates locally at lower cost.
Who is affected: Pharmaceutical and electronics manufacturers, chemical producers, chemistry and chemical engineering graduates, and investors tracking India's manufacturing and materials start-ups.
Key Takeaway
NuSynth's Rs 36.5 crore seed round, reported on October 13, 2026, is a bet that smarter chemistry can cut India's reliance on imported chemical intermediates.
Questions and Answers
What does NuSynth Technologies do?
NuSynth is a Bengaluru start-up that designs cheaper and less resource-heavy ways to make speciality chemicals, starting with chemicals used in pharmaceuticals and electronics.
How much did NuSynth raise and who invested?
It raised Rs 36.5 crore in a seed round co-led by Avaana Capital and Shastra VC, with seven to eight angel investors, as reported on October 13, 2026.
Where does NuSynth operate?
It runs a research laboratory and pilot plant in Mysuru and is developing another research facility in Bengaluru.
Why are speciality chemical start-ups attracting investors?
India still imports many chemical intermediates, and companies that can make them locally at a lower cost can sell into large pharmaceutical, electronics and consumer industries.
Disclaimer: Prepared by the Peepals newsroom from publicly available sources with AI assistance. Information is accurate to the best of our knowledge at the time of publication and may change. Images may be representative. Not professional advice. Report an error via our contact page.
Sourced and fact-checked by the Peepals Global Editorial Team
Reported, fact-checked and published by the Peepals Global Editorial Team.
